This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Psychotherapy Casebook

When Brief Therapy Worked and Medication Did Not

F. Andrew Kozel, MD; and Dean Schuyler, MD

Published: October 1, 2000

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Not long ago, long-term psychotherapy was recognized as the gold standard, and brief psychotherapy was the second-rate patch. Responding to a consumer mandate, a trend toward evidence-based medicine, and the regulatory impact of managed care, the positions are now reversed. There are, today, multiple models of brief therapy, and long-term therapy is difficult to find and is often seen as less desirable.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 2

Quick Links: Depression (MDD)

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...